Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Vaccine ; 2024 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-38341293

RESUMEN

During the COVID-19 pandemic, candidate COVID-19 vaccines were being developed for potential use in the United States on an unprecedented, accelerated schedule. It was anticipated that once available, under U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) or FDA approval, COVID-19 vaccines would be broadly used and potentially administered to millions of individuals in a short period of time. Intensive monitoring in the post-EUA/licensure period would be necessary for timely detection and assessment of potential safety concerns. To address this, the Centers for Disease Control and Prevention (CDC) convened an Advisory Committee on Immunization Practices (ACIP) work group focused solely on COVID-19 vaccine safety, consisting of independent vaccine safety experts and representatives from federal agencies - the ACIP COVID-19 Vaccine Safety Technical Work Group (VaST). This report provides an overview of the organization and activities of VaST, summarizes data reviewed as part of the comprehensive effort to monitor vaccine safety during the COVID-19 pandemic, and highlights selected actions taken by CDC, ACIP, and FDA in response to accumulating post-authorization safety data. VaST convened regular meetings over the course of 29 months, from November 2020 through April 2023; through March 2023 FDA issued EUAs for six COVID-19 vaccines from four different manufacturers and subsequently licensed two of these COVID-19 vaccines. The independent vaccine safety experts collaborated with federal agencies to ensure timely assessment of vaccine safety data during this time. VaST worked closely with the ACIP COVID-19 Vaccines Work Group; that work group used safety data and VaST's assessments for benefit-risk assessments and guidance for COVID-19 vaccination policy. Safety topics reviewed by VaST included those identified in safety monitoring systems and other topics of scientific or public interest. VaST provided guidance to CDC's COVID-19 vaccine safety monitoring efforts, provided a forum for review of data from several U.S. government vaccine safety systems, and assured that a diverse group of scientists and clinicians, external to the federal government, promptly reviewed vaccine safety data. In the event of a future pandemic or other biological public health emergency, the VaST model could be used to strengthen vaccine safety monitoring, enhance public confidence, and increase transparency through incorporation of independent, non-government safety experts into the monitoring process, and through strong collaboration among federal and other partners.

2.
Birth Defects Res ; 114(11): 559-576, 2022 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-35596682

RESUMEN

Traditional developmental toxicity testing practice examines fetal apical endpoints to identify a point of departure (POD) for risk assessment. A potential new testing paradigm involves deriving a POD from a comprehensive analysis of molecular-level change. Here, the rat ketoconazole endocrine-mediated developmental toxicity model was used to test the hypothesis that maternal epigenomic (miRNA) and transcriptomic (mRNA) PODs are similar to fetal apical endpoint PODs. Sprague-Dawley rats were exposed from gestation day (GD) 6-21 to 0, 0.063, 0.2, 0.63, 2, 6.3, 20, or 40 mg/kg/day ketoconazole. Dam systemic, liver, and placenta PODs, along with GD 21 fetal resorption, body weight, and skeletal apical PODs were derived using BMDS software. GD 21 dam liver and placenta miRNA and mRNA PODs were obtained using three methods: a novel individual molecule POD accumulation method, a first mode method, and a gene set method. Dam apical POD values ranged from 2.0 to 38.6 mg/kg/day; the lowest value was for placenta histopathology. Fetal apical POD values were 10.9-20.3 mg/kg/day; the lowest value was for fetal resorption. Dam liver miRNA and mRNA POD values were 0.34-0.69 mg/kg/day, and placenta miRNA and mRNA POD values were 2.53-6.83 mg/kg/day. Epigenomic and transcriptomic POD values were similar across liver and placenta. Deriving a molecular POD from dam liver or placenta was protective of a fetal apical POD. These data support the conclusion that a molecular POD can be used to estimate, or be protective of, a developmental toxicity apical POD.


Asunto(s)
MicroARNs , Animales , Femenino , Reabsorción del Feto , Humanos , Cetoconazol , MicroARNs/genética , Embarazo , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley
3.
Toxicol Rep ; 7: 844-851, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32714839

RESUMEN

A 90-day subchronic oral toxicity study was conducted to evaluate the safety of a consensus bacterial phytase variant 6-phytase (PhyG) for use as an animal feed additive. This phytase is produced by fermentation with a fungal (Trichoderma reesei) production strain expressing a biosynthetic variant of a consensus bacterial phytase gene assembled via ancestral reconstruction with sequence bias for the phytase from Buttiauxella sp. Rats were administered PhyG daily via oral gavage at dose-levels of 0 (distilled water), 250, 500 or 1000 mg total organic solids (TOS)/kg bodyweight (bw)/day (equivalent to 0, 112,500, 225,000 and 450,000 phytase units (FTU)/kg bw/day, respectively). No test article-related adverse effects were observed. A no-observed-adverse-effect level (NOAEL) for PhyG was established as 1000 mg TOS/kg bw/day, the highest test concentration. Based on this NOAEL and an estimate of broiler consumption determined from the proposed inclusion of the phytase in feed at the maximum recommended level (4000 FTU/kg), a margin of safety value of 1613 was calculated. Results of in vitro genotoxicity testing and in silico protein toxin evaluation further confirmed PhyG to be non-genotoxic and not likely to be a protein toxin upon consumption. These data support the safety of PhyG as an animal feed additive.

4.
AoB Plants ; 10(4): ply044, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-30090221

RESUMEN

Although the negative effects of root herbivores on plant fitness are expected to be similar to those of above-ground herbivores, the study of below-ground plant defences is limited compared to the rich literature on above-ground defences. Current theory predicts that concentrations of defensive chemicals above- and below-ground should be correlated, as the evolutionary drivers that shape plant defence are similar across the whole plant. We conducted a field study to measure root condensed tannin concentrations in Populus tremuloides, and determine how they related to leaf condensed tannin concentrations, tree position within the stand (edge vs. interior), tree size, and time of year. Overall, root tannin concentrations were substantially lower than leaf tannin concentrations. At individual sampling periods, root and leaf tannin concentrations were uncorrelated with each other, and did not vary with stand position or size. Across the growing season both root and leaf tannin concentrations did show similar trends, with both highest in the early summer, and declining through mid-summer and fall. These results suggest that the mechanisms that influence leaf and root tannin levels in aspen are independent within individual stems, possibly due to different evolutionary pressures experienced by the different tissue types or in response to localized (roots vs. foliage) stressors. However, across individual stems, the similar patterns in chemical defence over time, independent of plant size or stand position indicate that larger scale processes can have consistent effects across individuals within a population, such as the relative investment in defence of tissues in the spring versus the fall. Overall, we conclude that using theories based on above-ground defence to predict below-ground defences may not be possible without further studies examining below-ground defence.

5.
Regul Toxicol Pharmacol ; 92: 220-225, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29258926

RESUMEN

The aryloxyalkanoate dioxygenase-12 (AAD-12) protein is expressed in genetically modified soybean events DAS-68416-4 and DAS-444Ø6-6. Expression of the AAD-12 protein in soybeans confers tolerance to the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) providing an additional herbicide choice to farmers. This enzyme acts by catalyzing the degradation of 2,4-D into herbicidally inactive metabolites. To meet evolving interpretation of regulations in the European Union, three separate 28-day repeat-dose oral mouse studies were conducted at increasing doses of up to 1100 mg AAD-12 protein/kg bw/day. No treatment-related effects were seen in any of these three studies.


Asunto(s)
Ácido 2,4-Diclorofenoxiacético/toxicidad , Dioxigenasas/metabolismo , Glycine max/efectos de los fármacos , Herbicidas/toxicidad , Animales , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Ratones , Plantas Modificadas Genéticamente/efectos de los fármacos , Plantas Modificadas Genéticamente/metabolismo , Glycine max/metabolismo
6.
J Palliat Care ; 32(3-4): 89-91, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29110572

RESUMEN

Palliative care for children who can expect only a short life has expanded over the last decade. Greater understanding of the measures required to ensure comfort and acceptable quality of life within the critical care environment has grown in tandem. Some more invasive interventions may be considered a "step too far" by some practitioners, including feeding gastrostomy, contracture release, and tracheostomy. Tracheostomy can facilitate a number of measures, which may enhance the brief life of the child and their family. However, tracheostomy is associated with some challenges, which may make it less suitable for some families. We discuss 3 cases where this intervention was carried out.


Asunto(s)
Cuidados Paliativos/métodos , Pediatría/métodos , Calidad de Vida , Insuficiencia Respiratoria/terapia , Enfermo Terminal , Traqueostomía/métodos , Niño , Femenino , Humanos , Lactante , Masculino , Resultado del Tratamiento
7.
Toxicol Sci ; 154(1): 90-100, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-27492223

RESUMEN

Dietary administration is a relevant route of oral exposure for regulatory toxicity studies of agrochemicals as it mimics potential human intake of the chemical via treated crops and commodities. Moreover, dietary administration of test compounds during a developmental toxicity study can deliver a prolonged and stable systemic exposure to the embryo or fetus at all stages of development. In this study, strategies were employed to optimize rabbit test material consumption via diet. Comparative toxicokinetic profiles of gavage versus dietary administration were evaluated in pregnant or non-pregnant New Zealand White rabbits for 2 novel agrochemicals with different plasma half-lives of elimination (sulfoxaflor, t½ = 13.5 h and halauxifen, t½ = 1 h). Dietary administration of sulfoxaflor resulted in stable 24-h plasma concentrations, whereas gavage administration resulted in a 3-fold fluctuation in plasma levels between Cmax and Cmin Dietary administration of sulfoxaflor resulted in a 2-fold higher nominal and diurnal systemic dose when compared with gavage dosing due to Cmax-related maternal toxicity following gavage. Results with the shorter half-life molecule, halauxifen, were more striking with a 6-fold diurnal fluctuation by the dietary route compared with a 368-fold fluctuation between Cmax and Cmin by gavage. Furthermore, plasma halauxifen was detectable only up to 12 h following gavage but up to 24 h following dietary administration. Finally, the presence of these compounds in fetal blood samples was demonstrated, confirming that dietary exposure is appropriate for achieving fetal exposure. Collectively, the results of these studies support the use of dietary exposure in rabbit developmental toxicity studies.


Asunto(s)
Administración Oral , Agroquímicos/toxicidad , Pruebas de Toxicidad/métodos , Animales , Dieta , Femenino , Feto , Semivida , Embarazo , Piridinas/sangre , Piridinas/toxicidad , Conejos , Compuestos de Azufre/sangre , Compuestos de Azufre/toxicidad , Toxicocinética
8.
Artículo en Inglés | MEDLINE | ID: mdl-25652268

RESUMEN

Histiotrophic nutrition via the visceral yolk sac is an essential nutritional pathway of the rodent conceptus, and inhibition of this pathway may cause growth retardation, malformations, and death in rodent embryos. Morphologic differences among species during early development indicate that the visceral yolk sac histiotrophic nutrition pathway may be of lesser importance in nonrodent species, including humans. Here, comparative studies were conducted with inhibitors of different steps in the visceral yolk sac histiotrophic nutrition pathway to determine whether the rabbit is similarly responsive to the rat. Early somite stage New Zealand White rabbit and Crl:CD(SD) rat conceptuses (gestation day 9, rabbits; gestation day 10, rats) were exposed for 48 hr to three different histiotrophic nutrition pathway inhibitors using whole embryo culture techniques, after which they were evaluated for growth and malformations. Cubilin antibody, an inhibitor of endocytosis, reduced growth and development and increased malformations in both rat and rabbit embryos, although the rabbit appeared more sensitive. Leupeptin, a lysosomal cysteine protease inhibitor, also impaired growth and development and increased malformations in rat embryos, while in the rabbit it induced malformations and a slight decrease in morphology score but had no effect upon growth. Trypan blue, an inhibitor of endocytosis and endosome maturation, affected all measures in both species to a similar degree at the highest concentration (2500 µg/ml), but rat embryos responded to a greater extent at lower concentrations. Although the specific adverse outcomes appear to be different, these results demonstrate that rabbits, like rats, are sensitive to inhibitors of the histiotrophic nutrition pathway.


Asunto(s)
Fenómenos Fisiológicos Nutricionales de los Animales/efectos de los fármacos , Feto/efectos de los fármacos , Feto/fisiología , Animales , Anticuerpos/farmacología , Embrión de Mamíferos/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Femenino , Leupeptinas/farmacología , Conejos , Ratas Sprague-Dawley , Receptores de Superficie Celular/inmunología , Coloración y Etiquetado , Azul de Tripano/farmacología
9.
Chemosphere ; 120: 690-6, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25462314

RESUMEN

U.S. Environmental Protection Agency (US EPA) Regional Applied Research Effort (RARE) projects address the effects of environmental pollutants in a particular region on the health of the population in that region. This report is part of a RARE project that addresses this for the Penobscot Indian Nation (PIN), Penobscot Island, Maine, U.S., where the Penobscot River has had fish advisories for many years due to high levels of mercury. We used the Salmonella mutagenicity assay with strains TA100, TA98, YG1041, and YG1042 with and without metabolic activation to assess the mutagenic potencies of organic extracts of the Penobscot River water and sediment, as well as drinking-water samples, all collected by the PIN Department of Natural Resources. The source water for the PIN drinking water is gravel-packed groundwater wells adjacent to the Penobscot River. Most samples of all extracts were either not mutagenic or had low to moderate mutagenic potencies. The average mutagenic potencies (revertants/L-equivalent) were 337 for the drinking-water extracts and 177 for the river-water extracts; the average mutagenic potency for the river-sediment extracts was 244 revertants(g-equivalent)(-1). This part of the RARE project showed that extracts of the Penobscot River water and sediments and Penobscot drinking water have little to no mutagenic activity that might be due to the classes of compounds that the Salmonella mutagenicity assay detects, such as polycyclic aromatic hydrocarbons (PAHs), nitro-PAHs (nitroarenes), and aromatic amines. This study is the first to examine the mutagenicity of environmental samples from a tribal nation in the U.S.


Asunto(s)
Agua Potable/química , Monitoreo del Ambiente/estadística & datos numéricos , Sedimentos Geológicos/química , Mutágenos/toxicidad , Ríos/química , Contaminantes Químicos del Agua/toxicidad , Animales , Monitoreo del Ambiente/métodos , Humanos , Indígenas Norteamericanos , Maine , Pruebas de Mutagenicidad , Mutágenos/análisis , Hidrocarburos Policíclicos Aromáticos/análisis , Hidrocarburos Policíclicos Aromáticos/toxicidad , Salmonella/efectos de los fármacos , Contaminantes Químicos del Agua/análisis
10.
Reprod Toxicol ; 46: 46-55, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24598581

RESUMEN

High dose gavage administration of ethylene glycol (EG) induces teratogenicity in rodents, but not in rabbits, resulting from saturation of intermediate EG metabolism and glycolic acid (GA) accumulation. In vivo, rat embryos sequester GA 2-4-fold higher than maternal blood, a phenomenon absent in rabbits and proposed not to occur in humans. This research explored the mechanisms of GA disposition into rat and rabbit conceptuses using whole embryo culture (WEC). Rat and rabbit embryos concentrated GA from the culture medium. In vitro to in vivo discordance in the rabbit plausibly stemmed from anatomical differences between these models. GA sequestration was attenuated at 4°C in both species. Rat embryos further demonstrated pH-dependence of GA sequestration and inhibition by D-lactic acid. These data suggest GA disposition into rat and rabbit embryos is energy- and pH-dependent, and carrier-mediated. Anatomical and maternal-to-conceptal pH gradient differences likely underlie the lack of enhanced GA disposition in non-rodent species.


Asunto(s)
Embrión de Mamíferos/metabolismo , Glicolatos/metabolismo , Animales , Unión Competitiva , Técnicas de Cultivo de Embriones , Femenino , Concentración de Iones de Hidrógeno , Ácido Láctico/metabolismo , Embarazo , Proteínas/metabolismo , Conejos , Ratas , Ratas Sprague-Dawley , Temperatura
11.
Am J Obstet Gynecol ; 207(3 Suppl): S57-62, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22920061

RESUMEN

Maternal immunization with inactivated influenza vaccines is an important public health strategy to protect mothers and young infants from the serious complications of influenza. Although not contraindicated in pregnant women, currently US-licensed influenza vaccines are not specifically labeled for use during pregnancy. Several postmarketing initiatives are ongoing to obtain maternal and infant safety and immunogenicity data on US-licensed inactivated influenza vaccines used in pregnant women. The Food and Drug Administration is revising its pregnancy labeling regulations to improve the characterization and communication of risks of drugs and biologics used during pregnancy. To obtain a specifically labeled indication for use of an influenza vaccine during pregnancy, adequate and well-controlled prelicensure studies are needed to obtain data on the product's safety and effectiveness and to demonstrate protection of the mother and/or infant against influenza illness.


Asunto(s)
Regulación Gubernamental , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/prevención & control , Complicaciones Infecciosas del Embarazo/prevención & control , Atención Prenatal , Etiquetado de Productos/legislación & jurisprudencia , United States Food and Drug Administration , Ensayos Clínicos como Asunto , Femenino , Humanos , Vacunas contra la Influenza/efectos adversos , Embarazo , Vigilancia de Productos Comercializados , Estados Unidos , Vacunación/legislación & jurisprudencia , Vacunas de Productos Inactivados/administración & dosificación , Vacunas de Productos Inactivados/efectos adversos
12.
Methods Mol Biol ; 889: 239-52, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22669668

RESUMEN

Although the rabbit is used extensively in developmental toxicity testing, relatively little is known about the fundamental developmental biology of this species let alone mechanisms underlying developmental toxicity. This paucity of information about the rabbit is partly due to the historic lack of whole embryo culture (WEC) methods for the rabbit, which have only been made available fairly recently. In rabbit WEC, early somite stage embryos (gestation day 9) enclosed within an intact amnion and attached to the visceral yolk sac are dissected from maternal tissues and placed in culture for up to 48 h at approximately 37°C and are continuously exposed to an humidified gas atmosphere mixture in a rotating culture system. During this 48 h culture period, major phases of organogenesis can be studied including cardiac looping and segmentation, neural tube closure, and development of anlagen of the otic system, eyes and craniofacial structures, somites and early phases of limb development (up to bud stage), as well as expansion and closure of the visceral yolk sac around the embryo. Following completion of the culture period, embryos are evaluated based on several growth and development parameters and also are assessed for morphological abnormalities. The ability to sustain embryo development independent of the maternal system allows for exposure at precise development stages providing the opportunity study the direct action of a teratogen or one of its metabolites on the developing embryo. Rabbit WEC is perhaps most useful when used in conjunction with rodent WEC methods to investigate species-specific mechanisms of developmental toxicity.


Asunto(s)
Técnicas de Cultivo de Embriones , Crianza de Animales Domésticos , Animales , Embrión de Mamíferos/anomalías , Embrión de Mamíferos/efectos de los fármacos , Femenino , Masculino , Conejos , Proyectos de Investigación , Teratógenos/toxicidad , Pruebas de Toxicidad/métodos
13.
Birth Defects Res B Dev Reprod Toxicol ; 95(2): 107-15, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22461433

RESUMEN

N-(2-aminoethyl)ethanolamine (AEEA) caused aneurysms of the great vessels in rats exposed in utero and during the first days post partum, exacerbated by postnatal treatment of the lactating dams (Moore et al., 2012). The purpose of this work was to examine the systemic availability of AEEA during gestation and early lactation. The absorption of AEEA was determined following oral administration to nonpregnant and pregnant female Wistar rats. A single dose administered by gavage (0.5 or 50 mg/kg) on gestation day 18 was rapidly and extensively (>90%) absorbed from the gastrointestinal tract (absorption t(1/2) = 0.1-0.2 hr). Elimination from the plasma followed a biphasic pattern, with a rapid elimination phase (t(1/2 α) = 1.6-1.8 hr) followed by a slower phase (t(1/2 ß) = 16.7-17.3 hr). Following repeated gavage administration during gestation day 17 to 19, (14) C-AEEA-derived radioactivity readily partitioned into the fetus and was evenly distributed therein, but cleared approximately twofold slower from the fetal blood and tissues than the maternal blood and chorioallantoic placenta. When administered to lactating dams during lactation days 1 to 12, (14) C-AEEA-derived radioactivity preferentially partitioned into the milk reaching levels that were between 1.6- and 2.5-fold higher than the maternal blood. Although the concentration of AEEA equivalents in the maternal blood remained quite consistent, the concentration in the milk fell by almost 40% between lactation days 4 and 12, probably reflecting an increase in milk production over this same period. We confirm exposure of the offspring to AEEA both in utero and during lactation, but that AEEA does not appear to specifically concentrate in the great vessels.


Asunto(s)
Etanolaminas/farmacocinética , Etanolaminas/toxicidad , Feto/efectos de los fármacos , Leche/química , Efectos Tardíos de la Exposición Prenatal , Administración Oral , Animales , Animales Recién Nacidos , Relación Dosis-Respuesta a Droga , Femenino , Lactancia , Exposición Materna , Intercambio Materno-Fetal , Embarazo , Ratas , Ratas Wistar , Distribución Tisular
14.
Toxicol Sci ; 127(2): 522-34, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22461452

RESUMEN

Sulfoxaflor (X11422208), a novel agricultural molecule, induced fetal effects (forelimb flexure, hindlimb rotation, and bent clavicle) and neonatal death in rats at high doses (≥ 400 ppm in diet); however, no such effects occurred in rabbit dietary studies despite achieving similar maternal and fetal plasma exposure levels. Mode-of-action (MoA) studies were conducted to test the hypothesis that the effects in rats had a single MoA induced by sulfoxaflor agonism on the fetal rat muscle nicotinic acetylcholine receptor (nAChR). The studies included cross-fostering and critical windows of exposure studies in rats, fetal ((α1)(2)ß1γδ) and adult ((α1)(2)ß1δε) rat and human muscle nAChR in vitro agonism experiments, and neonatal rat phrenic nerve-hemidiaphragm contracture studies. The weight of evidence from these studies supported a novel MoA where sulfoxaflor is an agonist to the fetal, but not adult, rat muscle nAChR and that prolonged agonism on this receptor in fetal/neonatal rats causes sustained striated muscle contracture resulting in concomitant reduction in muscle responsiveness to physiological nerve stimulation. Fetal effects were inducible with as little as 1 day of exposure at the end of gestation, but were rapidly reversible after birth, consistent with a pharmacological MoA. With respect to human relevance, sulfoxaflor was shown to have no agonism on human fetal or adult muscle nAChRs. Taken together, the data support the hypothesis that the developmental effects of sulfoxaflor in rats are mediated via sustained agonism on the fetal muscle nAChR during late fetal development and are considered not relevant to humans.


Asunto(s)
Insecticidas/toxicidad , Contracción Muscular/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Agonistas Nicotínicos/toxicidad , Piridinas/toxicidad , Receptores Nicotínicos/efectos de los fármacos , Compuestos de Azufre/toxicidad , Factores de Edad , Animales , Animales Recién Nacidos , Relación Dosis-Respuesta a Droga , Femenino , Feto/efectos de los fármacos , Feto/metabolismo , Edad Gestacional , Humanos , Masculino , Exposición Materna , Músculo Esquelético/embriología , Músculo Esquelético/metabolismo , Embarazo , Efectos Tardíos de la Exposición Prenatal , Conejos , Ratas , Ratas Sprague-Dawley , Receptores Nicotínicos/genética , Receptores Nicotínicos/metabolismo , Proteínas Recombinantes/efectos de los fármacos , Proteínas Recombinantes/metabolismo , Reproducción/efectos de los fármacos , Medición de Riesgo , Xenopus laevis
15.
Pediatrics ; 127 Suppl 1: S23-30, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21502242

RESUMEN

The vaccine-approval process in the United States is regulated by the Center for Biologics Evaluation and Research of the US Food and Drug Administration. Throughout the life cycle of development, from preclinical studies to after licensure, vaccines are subject to rigorous testing and oversight. Manufacturers must adhere to good manufacturing practices and control procedures to ensure the quality of vaccines. As mandated by Title 21 of the Code of Regulations, licensed vaccines must meet stringent criteria for safety, efficacy, and potency.


Asunto(s)
Aprobación de Drogas/legislación & jurisprudencia , Evaluación de Medicamentos , Industria Farmacéutica/legislación & jurisprudencia , Vacunas/farmacología , Animales , Evaluación Preclínica de Medicamentos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Guías como Asunto , Humanos , Concesión de Licencias/legislación & jurisprudencia , Vigilancia de Productos Comercializados , Control de Calidad , Estados Unidos , United States Food and Drug Administration , Vacunas/efectos adversos
16.
Carbohydr Res ; 343(2): 301-7, 2008 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-18039535

RESUMEN

Lactobacillus acidophilus 5e2 when grown on skimmed milk, skimmed milk supplemented with sodium formate and skimmed milk supplemented with glucose secretes a branched heteropolysaccharide having a weight average molecular weight less than 450 kDa. The exopolysaccharide has a heptasaccharide repeat unit and is composed of D-glucose, D-galactose and N-acetyl-D-glucosamine in the molar ratio 3:3:1. Using chemical techniques and 1D and 2D-NMR spectroscopy the polysaccharide has been shown to possess the following repeat unit structure:


Asunto(s)
Lactobacillus acidophilus/química , Polisacáridos Bacterianos/química , Secuencia de Carbohidratos , Carbono/metabolismo , Espectroscopía de Resonancia Magnética , Datos de Secuencia Molecular , Peso Molecular
17.
Birth Defects Res B Dev Reprod Toxicol ; 80(3): 213-22, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17570508

RESUMEN

BACKGROUND: The rabbit is used extensively in developmental toxicity testing, yet basic information on rabbit embryo development is lacking. The goals of this study were to refine a rabbit embryo morphology scoring system, and use it to evaluate rabbit whole embryo cultures (WEC). METHODS: A total of 265 conceptuses were harvested between GD 8.0 and 12.0 (coitus = GD 0) at 6-hr intervals and examined in detail. Discreet developmental landmarks were then established for 18 morphological features and assigned scores ranging from 0 up to 6. The scoring system was then validated on a subset of randomly selected in vivo conceptuses, and was used to evaluate conceptuses grown for 12, 24, 36, or 48 hr in WEC beginning from GD 9.0 or 10.0. A few embryos also were examined using microscopic computed tomography (microCT)-based virtual histologytrade mark to assess the utility of this technology. RESULTS: Morphology scores of in vivo developed conceptuses increased linearly (r2 = 0.98) with advancing gestational age, from means of 0.0 on GD 8.0 to 67.9 on GD 12.0. Application of the scoring system, supplemented with evidence from Virtual histologytrade mark, indicated that the WEC system supported normal morphological development of rabbit conceptuses. However, when explanted at GD 9, the rate of development was about 20% slower than in vivo, whereas the rate of development in WEC from GD 10 was indistinguishable from in vivo. CONCLUSIONS: This work enhances the evaluation tools available to study mechanisms of normal and abnormal development in this widely used animal testing species.


Asunto(s)
Embrión de Mamíferos/fisiología , Preñez/fisiología , Conejos/embriología , Animales , Técnicas de Cultivo , Embrión de Mamíferos/anomalías , Embrión de Mamíferos/efectos de los fármacos , Embrión de Mamíferos/patología , Desarrollo Embrionario , Femenino , Embarazo , Toxicología/métodos
18.
Carbohydr Res ; 340(6): 1107-11, 2005 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-15797126

RESUMEN

Lactobacillus delbrueckii subsp. bulgaricus NCFB2074 when grown in skimmed milk secretes a highly branched exopolysaccharide. The exopolysaccharide has a heptasaccharide repeat unit and is composed of glucose and galactose in the molar ratio 3:4. Using chemical techniques and 1D and 2D NMR spectroscopy the polysaccharide has been shown to possess the following repeat unit structure: [carbohydrate structure: see text].


Asunto(s)
Lactobacillus delbrueckii/química , Polisacáridos Bacterianos/química , Secuencia de Carbohidratos , Espectroscopía de Resonancia Magnética , Peptidoglicano/química
19.
Carbohydr Res ; 338(1): 61-7, 2003 Jan 02.
Artículo en Inglés | MEDLINE | ID: mdl-12504382

RESUMEN

The exopolysaccharide (EPS) from Lactobacillus delbrueckii subsp. bulgaricus EU23 was perdeuteriomethylated and the perdeuteriomethylated EPS (pdm-EPS) purified by elution from a C(18) Sep-Pak cartridge. Both 1D and 2D NMR spectra were recorded for the pdm-EPS and these were interpreted to provide assignments for the individual 1H and 13C resonances of the sugar residues of the repeating unit. Using a combination of the results from monomer analysis and linkage analysis of the native EPS and the ROESY and HMBC NMR spectra of the pdm-EPS the following structure has been determined for the repeating unit:A process for characterising polysaccharides having low solubility in aqueous solution is reported.


Asunto(s)
Lactobacillus/química , Resonancia Magnética Nuclear Biomolecular , Polisacáridos Bacterianos/química , Conformación de Carbohidratos , Secuencia de Carbohidratos , Deuterio , Metilación , Datos de Secuencia Molecular , Estructura Molecular , Polisacáridos Bacterianos/aislamiento & purificación
20.
Am J Orthopsychiatry ; 55(2): 183-189, 1985 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3993748

RESUMEN

Recent psychological research has increased professional and public awareness of the problem of sexual intimacy between psychotherapists and their clients. A group therapy project for people who have been sexually involved with their therapists is described, and three major clinical issues encountered in these therapy sessions are discussed.


Asunto(s)
Adaptación Psicológica , Trastornos Mentales/terapia , Psicoterapia , Conducta Sexual , Adulto , Ira , Confidencialidad , Femenino , Humanos , Trastornos Mentales/psicología , Persona de Mediana Edad , Psicoterapia de Grupo , Autoimagen , Percepción Social
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...